Vaxcyte, Inc. Business Operations Contracts & Agreements
10 Contracts & Agreements
- Development Agreements (7 contracts)
- Indemnification Agreements (1)
- Sales Agreements (1)
- Supply Agreements (1)
- Amendment No. 1 to Sales Agreement, dated February 27, 2023, by and between Vaxcyte, Inc. and Jefferies LLC (Filed With SEC on February 27, 2023)
- Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd., dated October 21, 2016, as amended (Filed With SEC on November 7, 2022)
- Master Services Agreement for Drug Product Development and Manufacturing between the Registrant and Lonza Ltd., dated March 22, 2022, as amended (Filed With SEC on August 8, 2022)
- Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd., dated October 21, 2016, as amended (Filed With SEC on August 8, 2022)
- Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd., dated October 21, 2016, as amended (Filed With SEC on November 10, 2021)
- Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd, dated October 21, 2016, as amended (Filed With SEC on May 11, 2021)
- Supply Agreement by and between the Registrant and Sutro Biopharma, Inc., dated May 29, 2018 (Filed With SEC on May 22, 2020)
- Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd, dated October 21, 2016, as amended (Filed With SEC on May 22, 2020)
- Development and Manufacturing Services Agreement by and between the Registrant and Lonza Ltd, dated October 29, 2018 (Filed With SEC on May 22, 2020)
- Form of Indemnification Agreement to be entered into by and between the Registrant and each director and executive officer (Filed With SEC on May 22, 2020)
